Results 1 to 10 of about 78,274 (168)
Harnessing Cannabis sativa as a dual-use platform for biohydrogen production and pharmaceutical synthesis: a hypothesis and theory [PDF]
Cannabis sativa, long established as a cornerstone of the pharmaceutical and industrial fiber markets, represents a radical and underexplored platform for renewable energy innovation.
Lei P. Wang +3 more
doaj +2 more sources
Cannabis use and cannabis use disorder
Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10% of the 193 million cannabis users worldwide. The individual and public health burdens are less than those of other forms of drug use, but CUD accounts for a substantial proportion of persons seeking treatment for drug use disorders owing to the high global ...
Jason P. Connor +6 more
openaire +7 more sources
Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic
Background Cannabidiol (CBD) is a primary component in the cannabis plant; however, in recent years, interest in CBD treatments has outpaced scientific research and regulatory advancement resulting in a confusing landscape of misinformation and ...
Lucile Rapin +4 more
doaj +1 more source
The model of care at a leading medical cannabis clinic in Canada
Medical cannabis access has been legalized in more than 30 countries worldwide and popularity among patients is increasing rapidly. Cannabinoid-based treatments have been shown to be beneficial for several symptoms such as chemotherapy-induced nausea and
Erin Prosk +4 more
doaj +1 more source
Aim: Among treatments for chronic non-cancer pain (CNCP), cannabinoid-based medicines (CBMs) have become extremely popular. Evidence remains modest and limited primarily to delta-9-tetrahydrocannabinol (THC) for neuropathic pain; nevertheless, the use of
Lucile Rapin +5 more
doaj +1 more source
With the medical use of cannabis permitted in Canada since 2001, patients seek to use this botanical drug to treat a range of medical conditions. However, many healthcare practitioners express the need for further scientific evidence around the use of ...
Shaina P. Cahill +4 more
doaj +1 more source
Background The aim of the current study was to examine patterns of medical cannabis use in those using it to treat anxiety and to investigate if the anxiolytic effects of cannabis were impacted by gender and/or age. Methods Patient-reported data (n = 184
Meenu Minhas, Stephanie E. Lunn
doaj +1 more source
Cannabis prices and dynamics of cannabis use [PDF]
This paper uses duration models and self-reported cannabis histories from young Australians to study the dynamics of cannabis use. We find that low cannabis prices are associated with early initiation into cannabis use. While the decision to quit does not appear to be directly influenced by price, we find that the younger an individual is when they ...
van Ours, JC, Williams, J
openaire +8 more sources
Cannabis and schizophrenia [PDF]
Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations. Many people with schizophrenia smoke cannabis, and it is unclear why a large proportion do so and if the effects are harmful or beneficial. It is also unclear what the best method is to allow people with schizophrenia to alter their cannabis intake.To assess the effects
Jonathan A, Pushpa-Rajah +6 more
openaire +4 more sources
Medical cannabis authorization patterns, safety, and associated effects in older adults
Background Use of medical cannabis is increasing among older adults. However, few investigations have examined cannabis use in this population. Methods We assessed the authorization patterns, safety, and effects of medical cannabis in a sub-analysis of ...
Laura MacNair +8 more
doaj +1 more source

